Delivery Order SPE2DB20D1102-SPE2DB25FC6PC
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,506.26 to AmerisourceBergen Drug Corp for the supply of Annovera vaginal rings. This competitive award, issued on September 24, 2025, with an ultimate completion date of September 25, 2025, is structured as a firm fixed price delivery order with no set-aside designation. The contract will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency has awarded a delivery order valued at $2,387.01 to AmerisourceBergen Drug Corp for Annovera vaginal rings. This is a firm fixed-price, competitively awarded contract with a completion date of September 23, 2025, and represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,227.19 to AmerisourceBergen Drug Corp for Annovera vaginal rings, a contraceptive pharmaceutical product. Issued on June 6, 2025, with an ultimate completion date of June 9, 2025, this firm fixed-price delivery order represents a non-competitive set-aside and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Annovera vaginal rings, valued at $8,469.84 under a firm fixed price contract. The order was competitively awarded without set-aside designation and is scheduled for completion by September 10, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,861.62 to AmerisourceBergen Drug Corp for the supply of Annovera vaginal rings. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 12, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation and represents a pediatric/women's health pharmaceutical product addition to the DLA's medical supply...
- The Defense Logistics Agency awarded a $2,570.43 firm fixed price delivery order to AmerisourceBergen Drug Corp for Annovera vaginal rings on August 12, 2025, with an ultimate completion date of August 13, 2025. This non-set-aside competitive award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work will be performed at the contractor's Corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,879.12 to AmerisourceBergen Drug Corp for Annovera vaginal rings on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded contract represents a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...
- The Defense Logistics Agency awarded a delivery order valued at $2,954.22 to AmerisourceBergen Drug Corp for Annovera vaginal rings on September 5, 2025, with completion scheduled for September 8, 2025. This firm fixed-price, non-set-aside delivery order is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $4,323.44 to AmerisourceBergen Drug Corp for Annovera vaginal rings on March 11, 2025. This non-competitive, firm fixed-price delivery order is being fulfilled from the company's place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of March 12, 2025. The award represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government's medical supply chain....
- The Defense Logistics Agency awarded a delivery order totaling $1,377.53 to AmerisourceBergen Drug Corp for Annovera vaginal rings on June 2, 2025, with completion expected by June 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, placed against AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The contract will be performed at AmerisourceBergen's...
- SPE2DB20D1102Indefinite Delivery Contract
- SPE2DB20D1102-SPE2DB25FC6PCDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,620.00 to AmerisourceBergen Drug Corp for the supply of Annovera vaginal rings, with an ultimate completion date of July 18, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract to be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the DLA's Medical Supply Chain. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive prime contract vehicle enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally, including specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains, serving customers such as the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 7/17/25 |